Using a practical molecular capsular serotype prediction strategy to investigate Streptococcus pneumoniae serotype distribution and antimicrobial resistance in Chinese local hospitalized children

被引:14
作者
Jin, Ping [1 ,2 ]
Wu, Lijuan [3 ]
Oftadeh, Shahin [4 ,5 ]
Kudinha, Timothy [4 ,5 ,6 ]
Kong, Fanrong [4 ,5 ]
Zeng, Qiyi [1 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Pediat Ctr, Guangzhou 510282, Guangdong, Peoples R China
[2] Jinan Univ, Baoan Matern & Child Hlth Hosp, Paediat Intens Care Unit, Shenzhen, Peoples R China
[3] Jinan Univ, Baoan Matern & Child Hlth Hosp, Dept Clin Lab, Shenzhen, Peoples R China
[4] Univ Sydney, ICPMR Pathol West, Ctr Infect Dis, Westmead Hosp, Darcy Rd, Westmead, NSW 2145, Australia
[5] Univ Sydney, ICPMR Pathol West, Microbiol Lab Serv, Westmead Hosp, Darcy Rd, Westmead, NSW 2145, Australia
[6] Charles Sturt Univ, Orange, NSW, Australia
关键词
Streptococcus pneumoniae; serotype prediction; cpsB sequetyping; Sequential multiplex PCR; Antibiotic multidrug resistance; PNEUMOCOCCAL CONJUGATE VACCINES; INVASIVE-DISEASE; MULTIPLEX PCR; YOUNG-CHILDREN; SEROGROUPS; CARRIAGE; CLONE; 19A;
D O I
10.1186/s12887-016-0589-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: China is one of ten countries with the highest prevalence rate of pneumococcal infections. However, there is limited serotype surveillance data for Streptococcus pneumoniae, especially from the community or rural regions, partly due to limited serotyping capacity because Quellung serotyping is only available in few centers in China. The aim of this study was to develop a simple, practical and economic pneumococcal serotype prediction strategy suitable for future serotype surveillance in China. Methods: In this study, 193 S. pneumoniae isolates were collected from hospitalized children, 96.9 % of whom were <5 years old. The cpsB sequetyping, complemented by selective and modified USA CDC sequential multiplex-PCR, was performed on all the isolates, and serotypes 6A-6D specific PCRs were done on all serogroup 6 isolates. Based on systematic analysis of available GenBank cpsB sequences, we established a more comprehensive cpsB sequence database than originally published for cpsB sequetyping. Antibiotic susceptibility of all isolates was determined using the disk diffusion or E-test assays. Results: We built up a comprehensive S. pneumoniae serotype cpsB sequetyping database for all the 95 described serotypes first, and then developed a simple strategy for serotype prediction based on the improved cpsB sequetyping and selective multiplex-PCR. Using the developed serotype prediction strategy, 191 of 193 isolates were successfully "serotyped", and only two isolates were "non-serotypeable". Sixteen serotypes were identified among the 191 " serotypeable" isolates. The serotype distribution of the isolates from high to low was: 19 F (34.7 %), 23 F (17.1 %), 19A (11.9 %), 14 (7.3 %), 15B/15C (6.7 %), 6B (6.7 %), 6A (6.2 %), 9 V/9A (1.6 %); serotypes 6C, 3, 15 F/15A, 23A and 20 (each 1.1 %); serotypes 10B, 28 F/28A and 34 (each 0.5 %). The prevalence of parenteral penicillin resistance was 1.0 % in the non-meningitis isolates and 88.6 % in meningitis isolates. The total rate of multidrug resistance was 86.8 %. Conclusions: The integrated cpsB sequetyping supplemented with selective mPCR and serotypes 6A-6D specific PCRs "cocktail" strategy is practical, simple and cost-effective for use in pneumococcal infection serotype surveillance in China. For hospitalized children with non-meningitis penicillin-susceptible pneumococcal infections, clinicians still can use narrow-spectrum and cheaper penicillin, using the parenteral route, rather than using broader-spectrum and more expensive antimicrobials.
引用
收藏
页数:10
相关论文
共 35 条
[1]   Prevalence and correlates of treatment failure among Kenyan children hospitalised with severe community-acquired pneumonia: a prospective study of the clinical effectiveness of WHO pneumonia case management guidelines [J].
Agweyu, Ambrose ;
Kibore, Minnie ;
Digolo, Lina ;
Kosgei, Caroline ;
Maina, Virginia ;
Mugane, Samson ;
Muma, Sarah ;
Wachira, John ;
Waiyego, Mary ;
Maleche-Obimbo, Elizabeth .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2014, 19 (11) :1310-1320
[2]   Novel PCR-Restriction fragment length polymorphism method for determining serotypes or serogroups of Streptococcus pneumoniae isolates [J].
Batt, SL ;
Charalambous, BA ;
McHugh, TD ;
Martin, S ;
Gillespie, SH .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (06) :2656-2661
[3]   Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential [J].
Brueggemann, AB ;
Griffiths, DT ;
Meats, E ;
Peto, T ;
Crook, DW ;
Spratt, BG .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (09) :1424-1432
[4]   A New Pneumococcal Serotype, 11E, Has a Variably Inactivated wcjE Gene [J].
Calix, Juan J. ;
Nahm, Moon H. .
JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (01) :29-38
[5]   Burden of Pneumonia and Meningitis Caused by Streptococcus pneumoniae in China among Children under 5 Years of Age: A Systematic Literature Review [J].
Chen, Ying ;
Deng, Wei ;
Wang, Song-Mei ;
Mo, Qi-Mei ;
Jia, Huan ;
Wang, Qun ;
Li, Song-Guang ;
Li, Xiang ;
Yao, Bao-Dong ;
Liu, Cheng-Jun ;
Zhan, Yi-Qiang ;
Ji, Chen ;
Lopez, Anna Lena ;
Wang, Xuan-Yi .
PLOS ONE, 2011, 6 (11)
[6]   Streptococcus pneumoniae serotype 19A in children, South Korea [J].
Choi, Eun Hwa ;
Kim, So Hee ;
Eun, Byung Wook ;
Kim, Sun Jung ;
Kim, Nam Hee ;
Lee, Jina ;
Lee, Hoan Jong .
EMERGING INFECTIOUS DISEASES, 2008, 14 (02) :275-281
[7]  
Clinical and Laboratory Standards Institute, 2015, M100S25 CLIN LAB STA, V31, p[90, M100]
[8]   Serotype 14 variants of the Spanish penicillin-resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA-pbp1a region [J].
Coffey, TJ ;
Daniels, M ;
Enright, MC ;
Spratt, BG .
MICROBIOLOGY-SGM, 1999, 145 :2023-2031
[9]   Impact of conjugate pneumococcal vaccines on antibiotic resistance [J].
Dagan, Ron ;
Klugman, Keith P. .
LANCET INFECTIOUS DISEASES, 2008, 8 (12) :785-795
[10]   The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II [J].
Hausdorff, WP ;
Bryant, J ;
Kloek, C ;
Paradiso, PR ;
Siber, GR .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) :122-140